Madhav Dhodapkar, MBBS

/content/dam/www/provider-photos/d/madhav-dhodapkar/provider-madhav-dhodapkar-directory-1x.jpg
/content/dam/www/provider-photos/d/madhav-dhodapkar/provider-madhav-dhodapkar-directory-2x.jpg
Dhodapkar
Madhav Dhodapkar, MBBS

Madhav Dhodapkar, MBBS

  • Scientific Director, Multiple Myeloma Program, Fred Hutch
  • Professor, Translational Science and Therapeutics Division, Fred Hutch
  • Milton B. Rubin Family Endowed Chair, Fred Hutch
  • Professor, Division of Hematology and Oncology, University of Washington School of Medicine

Hematology-Oncology

“I view my relationship with each patient as a long-term partnership.”

— Dr. Dhodapkar


How would you describe your approach to care?  

My goal is to deliver patient care that is adapted to every patient's needs, goals and aspirations.  

What do you want patients to know about you? 

I am a physician-scientist who specializes in the treatment of myeloma. I have more than 25 years of clinical experience in the outpatient care of patients with plasma cell disorders, and I also serve as inpatient attending on the hematologic malignancies/transplantation service. I have also been engaged in clinical research testing new therapies in patients with plasma cell and related disorders including myeloma, amyloidosis and macroglobulinemia. 

Provider Background

Area of Clinical Practice
Multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), AL amyloidosis, Waldenström macroglobulinemia, plasma cell disorders

I am a hematologist-oncologist with expertise in blood and marrow transplant and immunotherapy who specializes in treating multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), AL amyloidosis, Waldenström macroglobulinemia and related plasma cell disorders. I see patients at the Sloan Clinic.

Diseases Treated

Languages

English
Hindi

Education, Experience and Certifications

Medical Degree
All India Institute of Medical Sciences

Residency
St. Louis University, Internal Medicine

Fellowship
Mayo Clinic, Hematology/Medical Oncology

Board Certification
Hematology, 1994; Medical Oncology 1995, American Board of Internal Medicine

Awards

National Cancer Institute Outstanding Investigator Award, 2016

NIH Director’s Transformative Research Award, 2010

Stories

All news
Gratitude for life-saving care at Fred Hutch leads to endowed chair Dr. Madhav Dhodapkar is the recipient of the Milton B. Rubin Family Endowed Chair August 19, 2025
Multiple myeloma is treatable, not curable. Is that set to change? Some experts believe a ‘functional cure’ is already within reach April 3, 2025

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you.

Fina a Clinical Trial Led by Dr. Dhodapkar

Publications

Many of our Fred Hutch physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written.

View Dr. Dhodapkar's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.